Condition: Pancreatic Ductal Adenocarcinoma · Hereditary Diseases · Pancreatitis, Chronic · Sponsor: Masaryk Memorial Cancer Institute
Pancreatic cancer is one of the diseases with the worst prognosis, which is mainly due to the initial asymptomatic prognosis. Unfortunately, the incidence of this disease in the Czech Republic is still increasing. In a certain proportion of patients, it is possible to predict the disease, e.g. due to family burdens. Regular follow-up of such individuals is the subject of the SCREPAN study: "Pancreatic Cancer Screening in High-Risk Persons".
This description comes directly from the study's public registry record.
Martina Lojova, Ph.D. · +420543136232 · martina.lojova@mou.cz
Dita Kozakova, Ing. · +420543136236 · dita.kozakova@mou.cz
Always discuss trial participation with your own doctor first.
| Masaryk Memorial Cancer Institute | Brno, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06330441